Sign in

CIK 0001022899

  • Non-accelerated filer
  • Smaller reporting company

Protagenic Therapeutics, Inc.new

Sign in to watch
Ticker
PTIX
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
061390025
Phone
+1 212-994-8200
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4/A Open-market buy Exec VP, Corporate Development bought 15,000 shares at an average $1.90 ($28,458)
  4. 4 Open-market buy Exec VP, Corporate Development bought 15,000 shares at an average $1.90 ($28,458)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Shares withheld for taxes Interim CFO gave up 9,718 shares (to pay taxes)
  12. 4 Other disposition Director disposed of 20,000 shares (other)
  13. 4 Other acquisition Director acquired 41,049 shares (other)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy 10% owner bought 777,992 shares at an average $0.69 ($534,337)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award Director acquired 40,000 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 4 of 7 · 137 filings